[Asia Economy Reporter Minji Lee] Korea Biogen announced on the 12th that it will halt production to carry out renovation work aimed at strengthening process safety management and increasing productivity at the production facilities of its 2nd plant located in Goesan, Chungbuk.



The sales amount for the production halt area is approximately 11.8 billion KRW. The company stated, "We have already secured inventory by conducting advance production based on expected sales volume during the construction period," and added, "We plan to increase the operating rate of the 1st plant, so there will be no impact on sales."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing